|
Life Sciences Technology Search, Evaluation, Acquisition and Investment
The Trillium Team has the background, expertise and hands-on experience to find
and evaluate early stage, life science technologies for future commercial potential.
In order to find the break-through, innovative, and cutting-edge technologies, the
principals of Trillium have developed relationships with medical schools, research
facilities, and individuals who discover and/or create new medical technologies in
the pre-seed, seed, and start-up stages. These relationships afford Trillium the
opportunity to find, evaluate and obtain or lock-up newly discovered technologies,
often before other potentially interested parties learn of the opportunities. The
Team’s access to pre-seed-stage opportunities through their direct university affiliations
provides a competitive advantage in its targeted segment of life science search, evaluation,
acquisition and investment and allows us to provide the following services:
-
Identification and scientific evaluation of break-through,
innovative, cutting-edge technologies
-
Evaluation of the future commercial potential of early
stage technologies
-
Identification and evaluation of product opportunities/alliance
opportunities
-
Competitive assessment of technologies/products
-
Preparation of risk assessment, liquidity, strategies, and diversification
positions
-
Structure, negotiate and close private equity investments
|
|